Esophageal Cancer clinical trials

Explore recruiting esophageal cancer clinical trials.

Recruiting esophageal cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Esophageal Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Nivolumab during active surveillance after neoadjuvant chemoradiation for esophageal cancer: SANO-3 study

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With or Without Pembrolizumab (MK‑3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer Previously Exposed to PD-1/PD-L1 Treatment (KEYMAKER-U06): Substudy 06B

Norway, Germany, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Esophageal, or Gastroesophageal Junction Cancer

Belgium, Spain, Romania, Ireland, Czechia, France +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

HERES trial: Trastuzumab and standard treatment with chemo- and immunotherapy as first line treatment for HER2 positive esophageal squamous cell carcinoma patients

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized multicenter clinical trial in patients with primary resectable esophageal carcinoma (cT1-4, N0-3, M0)

Belgium, Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Dual-Wavelength Quantitative Fluorescence Endoscopy for Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer: A Phase I Multicenter Feasibility and Safety Study

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Esophageal Cancer trials by city

Esophageal Cancer in Toronto Esophageal Cancer in Vancouver Esophageal Cancer in Montreal Esophageal Cancer in Calgary Esophageal Cancer in Edmonton Esophageal Cancer in Ottawa Esophageal Cancer in Winnipeg Esophageal Cancer in Quebec City Esophageal Cancer in Hamilton Esophageal Cancer in Kitchener Esophageal Cancer in London Esophageal Cancer in Halifax Esophageal Cancer in New York Esophageal Cancer in Los Angeles Esophageal Cancer in Chicago Esophageal Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease